Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.

Clinical validation testing proved CleaRecon DL’s 3D image reconstructions to be effective at reducing unwanted artifacts, offering clearer images in 98% of cases.

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.

Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs. 

Interventional radiologists play a crucial role in stopping or controlling bleeding in these patients, but their effectiveness is often hindered by time.

Tom Price, MD, an orthopedic surgeon, and former secretary of Health and Human Services (HHS) is an advocate for changing immigration policy to help solve the growing shortage of doctors and nurses in the U.S.

The piece in question, which features a red heart-shaped balloon, has an unusual origin story, even by Banksy’s standards. 

Why do investors equate these companies with beautiful, mythical beasts? Because startups with such dazzling attributes are—or long were—rarely seen.

“Substantial” growth in CT and MRI is replacing lower-cost modalities such as X-ray and ultrasound, experts write in JACR. 

A total of 19 diagnostic radiology residents died between 2000 to 2021, including six by neoplastic disease and five from suicide, researchers write in JAMA.